Medical monitor cabinets

Ai Class II Type A2 biosafety cabinet features NSF certified Great for COVID-19 specimen handling Motorized front glass viewing window with remote foot switch Dual HEPA filters with life indicator UV light life indicator Waterproof in-chamber power

SRIF-28.

SRIF-28.

UFP-505.

UFP-505.

PF-AKT400 is a broadly selective, potent, ATP-competitive Akt inhibitor, displays 900-fold greater selectivity for PKBα ( IC 50 =0.5 nM) than PKA ( IC 50 =450 nM).In VitroPF-AKT400 (Compound 42) provides significantly enhanced selectivity for Akt

PF-AKT400 is a broadly selective, potent, ATP-competitive Akt inhibitor, displays 900-fold greater selectivity for PKBα ( IC 50 =0.5 nM) than PKA ( IC 50 =450 nM).In VitroPF-AKT400 (Compound 42) provides significantly enhanced selectivity for Akt

PF-AKT400 is a broadly selective, potent, ATP-competitive Akt inhibitor, displays 900-fold greater selectivity for PKBα ( IC 50 =0.5 nM) than PKA ( IC 50 =450 nM).In VitroPF-AKT400 (Compound 42) provides significantly enhanced selectivity for Akt

PF-AKT400 is a broadly selective, potent, ATP-competitive Akt inhibitor, displays 900-fold greater selectivity for PKBα ( IC 50 =0.5 nM) than PKA ( IC 50 =450 nM).In VitroPF-AKT400 (Compound 42) provides significantly enhanced selectivity for Akt

PF-AKT400 is a broadly selective, potent, ATP-competitive Akt inhibitor, displays 900-fold greater selectivity for PKBα ( IC 50 =0.5 nM) than PKA ( IC 50 =450 nM).In VitroPF-AKT400 (Compound 42) provides significantly enhanced selectivity for Akt

Product description：TBCA is a highly selective CK2 (casein kinase II) inhibitor with an IC50 of 110 nM and a Ki of 77 nM. TBCA shows selectivity for CK2 over CK1, DYRK1A and a panel of 27 other kinases.

Product description：TBCA is a highly selective CK2 (casein kinase II) inhibitor with an IC50 of 110 nM and a Ki of 77 nM. TBCA shows selectivity for CK2 over CK1, DYRK1A and a panel of 27 other kinases.